{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:04:11Z","timestamp":1785510251777,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ejogrb.2013.09.029","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T22:04:12Z","timestamp":1382133852000},"page":"51-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Normal cut-off values for hyperandrogenaemia in Iranian women of reproductive age"],"prefix":"10.1016","volume":"172","author":[{"given":"Somayeh","family":"Hashemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Ramezani Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Noroozzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2013.09.029_bib0005","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1210\/jc.2009-1908","article-title":"Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome?","volume":"95","author":"Stener-Victorin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0010","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0015","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0020","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","article-title":"Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus","volume":"77","author":"Ovalle","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/8.3.231","article-title":"Long-term health consequences of PCOS","volume":"8","author":"Wild","year":"2002","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0035","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0140-6736(03)13409-5","article-title":"Polycystic ovary syndrome and endometrial carcinoma","volume":"361","author":"Hardiman","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.beem.2006.03.007","article-title":"Diagnosis of hyperandrogenism: biochemical criteria","volume":"20","author":"Stanczyk","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0045","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/193229681000400218","article-title":"Effects of controlled-release alpha lipoic acid in lean, nondiabetic patients with polycystic ovary syndrome","volume":"4","author":"Masharani","year":"2010","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0050","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/humupd\/dmp024","article-title":"Visually scoring hirsutism","volume":"16","author":"Yildiz","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0065","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1210\/jc.2004-2301","article-title":"Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism","volume":"91","author":"DeUgarte","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1477-7827-9-39","article-title":"The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study","volume":"9","author":"Tehrani","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0075","unstructured":"Eisen M. Cluster 3.0 manual. Available at: http:\/\/bonsai.ims.u-tokyo.ac.jp\/\u223cmdehoon\/software\/cluster\/cluster3.pdf."},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0080","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejogrb.2010.10.021","article-title":"Determining the normal cut-off levels for hyperandrogenemia in Chinese women of reproductive age","volume":"154","author":"Zhao","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0085","unstructured":"http:\/\/www.statsoft.com\/textbook\/cluster-analysis\/#k."},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0090","unstructured":"http:\/\/home.deib.polimi.it\/matteucc\/Clustering\/tutorial_html\/kmeans.html."},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0095","unstructured":"Robinson F, et al. http:\/\/www.dlhoffman.com\/\u223choffman\/papers\/StartingPointAnalysis.doc."},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/jama.1968.03140060001001","article-title":"The length and variability of the human menstrual cycle","volume":"203","author":"Chiazze","year":"1968","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0110","first-page":"77","article-title":"Variation of the human menstrual cycle through reproductive life","volume":"12","author":"Treloar","year":"1967","journal-title":"Int J Fertil"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0115","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.0001-6349.2004.00373.x","article-title":"Clinical, biochemical and ultrasonographic characteristics of Scandinavian women with PCOS","volume":"83","author":"Vanky","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1515\/CCLM.2007.031","article-title":"Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome","volume":"45","author":"Hahn","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0125","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1177\/147323001103900443","article-title":"Hirsutism score and the severity of hyperandrogenism associated with polycystic ovary syndrome in the southeastern region of Turkey","volume":"39","author":"Demir","year":"2011","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0130","series-title":"Cluster analysis","author":"Sireci","year":"2000"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0135","series-title":"Annual meeting of the American Psychological Association","article-title":"Using cluster analysis to solve the problem of standard setting","author":"Sireci","year":"1995"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0140","unstructured":"http:\/\/www.cgl.ucsf.edu\/cytoscape\/cluster\/clusterMaker.html."},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0145","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/sj.ijir.3901178","article-title":"Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: part A. Serum androgen levels in women aged 20\u201349 years with no complaints of sexual dysfunction","volume":"16","author":"Guay","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0155","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.fertnstert.2005.10.054","article-title":"Obesity and androgens: facts and perspectives","volume":"85","author":"Pasquali","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0160","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brainres.2010.08.088","article-title":"Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity","volume":"1364","author":"Rosenfield","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0165","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jcem.82.8.4160","article-title":"Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging","volume":"82","author":"Labrie","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1677\/joe.0.1540057","article-title":"Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects","volume":"154","author":"Sulcova","year":"1997","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0175","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0165-0173(01)00133-3","article-title":"Age-related changes of the adrenal secretory pattern: possible role in pathological brain aging","volume":"37","author":"Ferrari","year":"2001","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0180","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1530\/EJE-09-0741","article-title":"Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography\u2013tandem mass spectrometry and analysis by plots","volume":"162","author":"Barth","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0185","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5001\/omj.2012.112","article-title":"Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism","volume":"27","author":"Al Kindi","year":"2012","journal-title":"Oman Med J"},{"key":"10.1016\/j.ejogrb.2013.09.029_bib0190","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement. Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151300482X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151300482X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T19:22:57Z","timestamp":1768245777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121151300482X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":38,"alternative-id":["S030121151300482X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2013.09.029","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normal cut-off values for hyperandrogenaemia in Iranian women of reproductive age","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2013.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}